Gladstone NOW: The Campaign Join Us on the Journey ✕
811 - 825 of 1459 Results Clear All
People from around the world donate money and equipment to accelerate science at Gladstone
Donor Stories COVID-19
New York Academy of Sciences—New York Academy of Sciences: Many winners of the NYAS Blavatnik Award for Young Scientists have redirected their research efforts to focus on COVID-19. These include Gladstone Senior Investigators Leor Weinberger and Nevan Krogan.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Krogan Lab Weinberger Lab
The Daily Star—Mir Khalid, a graduate student at Gladstone Institutes, participated in CoronaCast, a Facebook platform intended to share research-based information about the pandemic.
Graduate Organization GO COVID-19
MEAWW—Gladstone Investigator Nevan Krogan describes his efforts to identify drugs that affect COVID-19, including the finding that a component of cough syrup may have the undesirable effect of improving viral replication.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
Vallejo Times-Herald—Gladstone virologist Warner Greene speculates that while social distancing has helped keep the coronavirus in check in the Bay Area, people in warmer Southern California may be experiencing “COVID-19 fatigue”, and their increased outings are allowing the virus to spread.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Cardiac effects of COVID-19 are starting to show in patients and researchers are ready to fight it.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab CRISPR/Gene Editing Organoids
Watch the first video in the Newton Webinar Series and learn how genes sculpt our hearts.
Cardiovascular Disease Bruneau Lab
The Mercury News—Bay Area research organizations, including Gladstone Institutes, are leading the hunt for COVID-19 therapies and preventative strategies.
Gladstone Experts COVID-19
San Francisco Chronicle—Gladstone Senior Investigator Nevan Krogan describes his team’s rapid response to the COVID-19 pandemic, and how by mapping the interactions between SARS-CoV-2 and human cells they hope to identify ways to eliminate the deadly virus.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
Learn more about CRISPR, a disruptive technology influencing advances in treatment and cures of diseases through gene editing.
Gladstone Experts Data Science and Biotechnology Conklin Lab CRISPR/Gene Editing
New York Times—Gladstone Investigator Nevan Krogan describes his team’s effort to identify drugs that target the human proteins that interact with SARS-CoV-2, and the hope that this effort may lead to effective therapies for COVID-19 that can move rapidly through the testing and approval process.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
San Francisco Chronicle—Gladstone Senior Investigator Nevan Krogan explains his team’s efforts to understand how COVID-19 interacts with human cells, and how they are using that information to identify drugs that could be used to fight the virus.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
The Mercury News—Nevan Krogan explains his team’s approach to finding drugs to confront the COVID-19 pandemic: hunting for drugs that target the human proteins on which the virus relies.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
NBC Bay Area—Senior Investigator Nevan Krogan describes his team’s effort to identify drugs that disrupt the interactions between human cells and SARS-CoV-2, the virus that causes COVID-19.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
KQED—Gladstone Senior Investigator Nevan Krogan and his team found that many drugs already approved by the FDA for other purposes may be useful to treat COVID-19. The research also reveals that an ingredient commonly found in cough suppressants can cause the SARS-CoV-2 virus to grow more quickly in the lab setting.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
